STOCK TITAN

Blackbaud (BLKB) grants director Deneen DeFiore 7,834 restricted shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

DeFiore Deneen reported acquisition or exercise transactions in this Form 4 filing.

Blackbaud Inc. director Deneen DeFiore received a grant of 7,834 shares of restricted common stock on August 3, 2026. All of these shares are scheduled to vest on August 3, 2027, or earlier immediately before the company’s 2027 annual election of directors, provided she is then serving as a director. Following this award, she directly holds 17,903 common shares.

Positive

  • None.

Negative

  • None.
Insider DeFiore Deneen
Role Director
Type Security Shares Price Value
Grant/Award Common Stock F1 7,834 $0.00 $0.00
Holdings After Transaction: Common Stock — 17,903 shares (Direct)
Footnotes (1)
  1. F1. Represents a restricted stock award, all of which shall vest on August 3, 2027 or, if earlier, immediately prior to the 2027 annual election of directors of the Company, provided that the reporting person is then serving as a director of the Company.
Restricted stock granted 7,834 shares Grant of restricted common stock to director Deneen DeFiore on August 3, 2026
Post-transaction holdings 17,903 shares Total direct Blackbaud common stock holdings after the grant
Vesting date August 3, 2027 Date when all 7,834 restricted shares are scheduled to vest, subject to continued board service
restricted stock award financial
"Represents a restricted stock award, all of which shall vest on August 3, 2027"
A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.
annual election of directors regulatory
"immediately prior to the 2027 annual election of directors of the Company"
A regular, yearly vote by a company’s shareholders to choose who will sit on the board of directors; nominees are presented, votes are cast in person or by proxy at a meeting or by ballot, and winners serve until the next annual election. It matters to investors because the board directs corporate strategy, hires and supervises management, and sets governance and risk policies — similar to electing a steering committee that guides how the company is run.
director of the Company regulatory
"provided that the reporting person is then serving as a director of the Company"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What equity award did Blackbaud (BLKB) director Deneen DeFiore receive?

Blackbaud director Deneen DeFiore received a restricted stock award of 7,834 common shares. This equity grant was reported as a Form 4 transaction coded “A,” indicating a grant or award acquisition rather than an open-market purchase or sale.

When will Deneen DeFiore’s 7,834 Blackbaud (BLKB) restricted shares vest?

The 7,834 restricted shares are scheduled to vest on August 3, 2027. Vesting may occur earlier, immediately before Blackbaud’s 2027 annual election of directors, if DeFiore is then serving as a director of the company, according to the award terms.

How many Blackbaud (BLKB) shares does Deneen DeFiore hold after this grant?

After the restricted stock grant, Deneen DeFiore directly holds 17,903 shares of Blackbaud common stock. This total includes the newly awarded 7,834 restricted shares reported in the Form 4 filing for the August 3, 2026 transaction.

Is DeFiore’s Blackbaud (BLKB) restricted stock award contingent on continued board service?

Yes. The restricted stock award vests only if DeFiore is serving as a director at vesting. All 7,834 shares vest on August 3, 2027, or earlier immediately before the 2027 annual election of directors, provided she remains on Blackbaud’s board.

Was DeFiore’s Blackbaud (BLKB) stock transaction under a Rule 10b5-1 trading plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not marked, meaning this reported transaction was not affirmed as being executed under a Rule 10b5-1 pre-arranged trading plan but instead reflects a compensation-related stock grant.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DeFiore Deneen

(Last)(First)(Middle)
65 FAIRCHILD STREET

(Street)
CHARLESTON SOUTH CAROLINA 29492

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
BLACKBAUD INC [ BLKB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/03/2026A7,834(1)A$017,903D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents a restricted stock award, all of which shall vest on August 3, 2027 or, if earlier, immediately prior to the 2027 annual election of directors of the Company, provided that the reporting person is then serving as a director of the Company.
Remarks:
/s/ S. Halle Vakani, Attorney-in-Fact08/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)